MedTrace Logo

Inflammation and Electroconvulsive Therapy

NCT02095639 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2018-02-14

No results posted yet for this study

Summary

The purpose of this study is to explore whether electroconvulsive therapy (ECT) accidentally leads to a side effect of brain inflammation. Patients with treatment resistant depression who are planning to take ECT will be subsequently approached to participate in the study.

Conditions

Sponsors & Collaborators

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Jeffrey H Meyer, MD, PhD · Research Imaging Centre, Centre for Addiction and Mental Health

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02095639 on ClinicalTrials.gov